Physician

David Nelson Oubre, M.D.

According to 2025 Medicare claims, David Oubre, M.D. (NPI: 1104883305) practices hematology/oncology in the Slidell-Mandeville-Covington, LA market, with the plurality of this provider's patient population coming from St. Tammany, LA. This provider's primary affiliated billing organization is PONTCHARTRAIN CANCER CENTER INC (NPI: 1811916109; TIN: 203218016) and primary practice location at 70433-7512.

Oubre's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 481 traditional Medicare patients, billed 201,607 HCPCS/CPT codes, and received $2,159,295 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,630 prescription claims across 270 beneficiaries totaling $8,437,586 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 55 claims. Open Payments data shows 162 records totaling $177,471. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $970,649 to $2,159,295. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,680,930 to $8,437,586. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $2,291 to $3,311.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	639	109,164	$970,649
2016	610	127,192	$1,279,018
2017	678	89,016	$1,130,220
2018	835	136,186	$1,893,811
2019	785	148,505	$1,854,789
2020	697	167,392	$2,018,546
2021	612	129,140	$1,795,953
2022	571	126,353	$1,804,369
2023	485	110,620	$1,904,114
2024	481	201,607	$2,159,295

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	270	1,571	$1,680,930
2016	249	1,666	$2,134,705
2017	217	1,085	$2,084,419
2018	305	1,608	$2,632,632
2019	327	1,748	$3,383,031
2020	344	1,996	$5,276,442
2021	321	1,826	$6,428,765
2022	302	1,545	$5,955,610
2023	253	1,521	$6,996,855
2024	270	1,630	$8,437,586

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	27	$1,512
2016	N/R	26	$1,089
2017	N/R	74	$10,394
2018	24	231	$8,396
2019	38	291	$16,390
2020	N/R	209	$12,673
2021	N/R	146	$9,566
2022	N/R	101	$6,161
2023	N/R	34	$939
2024	N/R	55	$3,285

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	90	112	$139
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	76	113	$138
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	314	906	$95
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	88	93	$63
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	155	173	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	51	1,444	$788,002
Ibrance	Palbociclib	43	1,204	$675,955
Lenalidomide	Lenalidomide	51	1,253	$648,129
Givlaari	Givosiran Sodium	13	386	$551,603
Calquence	Acalabrutinib Maleate	34	1,020	$515,157

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0781	Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient	Y	N/R	11	$2,063
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	22	$800
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	22	$422

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	137	$3,207	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	25	$174,264	BeiGene USA, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Nelson Oubre, M.D.?

Tedicare shows public-source Medicare data for David Nelson Oubre, M.D. (NPI 1104883305), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Nelson Oubre, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David Nelson Oubre, M.D.?

David Nelson Oubre, M.D. is linked to PONTCHARTRAIN CANCER CENTER INC (billing NPI 1811916109) in the available physician profile data.

Does David Nelson Oubre, M.D. have Open Payments data?

David Nelson Oubre, M.D. has 162 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.